HomepageNews & MediaArticles Details

Putting Medical Innovation to the Test How DEKRA Identifies Risks in Medical Devices

Nov 18, 2026Corporate

DEKRA’s site in the industrial park west of Arnhem is easy to spot: Its seven-story building complex and 4,000-square-meter product testing hall immediately catch the eye. It is also DEKRA’s only location in the Netherlands that offers testing and certification services for medical devices. “At this site, we handle more than 10,000 test orders each year for new and existing products,” explains Bram Holtus, Managing Director of DEKRA Certification.

When Notified Bodies Such as DEKRA Are Needed

In electromedical technology, manufacturers may assess certain simple, low-risk devices themselves. However, even devices that do not perform a life-sustaining function can pose risks to patients or staff. “A surgical light, for example, must reliably illuminate the surgical field without interfering with other medical devices or failing because of electromagnetic interference,” Holtus explains. For higher-risk medical devices, including those used in or around the body, manufacturers must involve a Notified Body such as DEKRA.

 No Innovation Without Risk

The range of products becomes clear only during a tour of the test rooms. It stretches from established devices such as patient monitors to highly innovative systems such as artificial pancreases. “Medical innovations can significantly improve patients’ lives, but they often have weaknesses at the outset,” Holtus says. “At DEKRA, our job is to identify these risks without slowing medical progress.”

 Testing Procedures Under IEC 60601

Depending on a product’s purpose, design, and risk level, DEKRA uses different procedures. In a shielded chamber, for example, experts evaluate electromagnetic compatibility (EMC) in accordance with IEC 60601-1-2. Other test stations focus on issues such as high voltage or unintended leakage currents. “It matters whether we are dealing with a new product or one that has already been tested,” Holtus explains. For a new product, DEKRA examines the entire system. If the work concerns specific changes, such as a new software version or a supplier change, DEKRA’s experts assess the change and its potential effects on the product as a whole.
At DEKRA, our job is to identify risks without slowing medical progress.
Bram Holtus, Managing Director of DEKRA Certification 

How Medical Device Certification Begins

When commissioning DEKRA to test a new medical device, the manufacturer must document in detail how the product works, its intended medical use, and the user group for which it is intended. Knowing which countries a device is designed for gives Holtus and his team important context, as medical infrastructure requirements can vary from region to region. “A few years ago, we were asked to test an incubator for premature babies that had been developed exclusively for regions with unreliable power supplies,” Holtus recalls.

DEKRA Determines the Risk Class of Medical Devices

Once the manufacturer has provided all relevant information, DEKRA reviews the device’s risk class, identifies the applicable requirements, and involves the necessary experts. A neurostimulation system shows how closely testing is tied to product engineering. The implant sends electrical pulses through electrodes to specific areas of the brain to support impaired bodily functions. If the pulses are too strong, or if several signals interact in an unfavorable way, the stimulation can put the patient at risk.

What Happens in the Event of a Failure?

DEKRA’s testing experts examine the entire system – from the pulse generator to the leads, battery, and software – and check whether key factors such as amplitude, frequency, and pulse duration stay within defined safety limits. In so-called failure-condition tests, they also simulate how potential defects could affect product safety. The system must not be susceptible to electromagnetic interference, and it must not interfere with other devices.

Cybersecurity in Medical Devices

During the tour of the two buildings, it quickly becomes clear that many test products contain digital components. “That is why we build cybersecurity into our testing procedures from the start,” Holtus explains. One possible threat scenario: If attackers manage to increase the insulin dose delivered by an artificial pancreas, the consequences could be fatal for the patient. That is why Holtus and his team consider cybersecurity aspects such as software, interfaces, and data connections alongside medical technology requirements. For each product, DEKRA assesses whether unauthorized users could access the system and manipulate safety-related settings.
We build cybersecurity into our testing procedures from the start.
Bram Holtus, Managing Director of DEKRA Certification

How Quality Management Works in Medical Technology

Two manufacturer-controlled factors are just as important for product safety: quality management and manufacturing processes. A safe prototype is not enough. The manufacturer must also show that every unit can be produced to the same quality standard and provide other evidence, such as clinical investigations, either directly or by commissioning qualified organizations. “For implanted solutions such as neurostimulators that remain in the body, the manufacturer must also demonstrate biocompatibility and sterility,” Holtus explains.

Conformity Assessment: Certification as the Final Step

DEKRA then brings all the results together. If test results do not meet the requirements, the manufacturer must correct the deviations and resubmit the relevant evidence. There is no fixed deadline. “Especially with new products, a little fine-tuning is often needed before they can be launched,” says the medical technology expert. In that case, DEKRA does not need to retest the entire product; it tests only the areas related to the issues that need to be corrected. If the product meets all requirements, DEKRA documents the assessment in a final report and issues the certificate.

How Long Does Testing Take – and What Happens Next?

It is difficult to give a general estimate for how long a testing process will take. “Still, testing a new product usually takes between two and nine months,” Holtus says. The timeline depends not only on the solution’s complexity but also on how well the manufacturer cooperates and, for example, how quickly it submits any missing documents.

Post-market surveillance begins once the testing and certification process is complete. The manufacturer must continuously document important events, while DEKRA uses regular and unannounced audits to check that quality and safety continue to be maintained.

A Look at Future Technologies

“My job fulfills a childhood dream: I have always been fascinated by pushing things to their limits in the lab and contributing to a safer society,” Holtus says. He and his team also get an early look at innovative technologies that have not yet reached the market, with capabilities that would have been hard to imagine just a few years ago. In the past, testing often focused on basic hazards such as electric shock or fire. Today, DEKRA increasingly deals with highly connected systems, complex software, and intelligent implants.
That means DEKRA’s testing experts need to look ahead and identify potential risks before the technology is used in everyday medical practice. “So it can’t be a coincidence that our test site is in a city whose coat of arms features a double-headed eagle,” Holtus says with a smile.
Would you like to have an active medical device or an in vitro diagnostic (IVD) device tested? DEKRA offers safety and performance testing to assess relevant product characteristics. Learn more: Healthcare and Medical Devices
DEKRA Testing of Active Medical Devices
DEKRA provides comprehensive testing for active medical devices and in vitro diagnostic (IVD) devices. Services cover electrical safety and electromagnetic compatibility, as well as usability, software, cybersecurity, and penetration testing. This helps manufacturers obtain the evidence they need for CE marking and access to markets worldwide.
More
Share page :